The International Contrast Ultrasound Society (ICUS) today announced a handy new chart that may be used to guide coding and ...
Stark law’s in-office ancillary services exception is one of the most commonly used exceptions because it allows physician ...
REMSleep Holdings has announced that it has received HCPCS approval from the Pricing, Data Analysis and Coding (PDAC) contractor for its DeltaWave nasal pillow system.
When clinicians and billing specialists see that AI can handle repetitive work accurately and safely, adoption accelerates.
Medicare Advantage health plans are blasting a government proposal this week that would keep their reimbursement rates flat next year while making other payment changes.
Incidence of psychotic disorders by birth cohort: a population-based cohort study in Ontario, Canada
Background: Previous reports have suggested that the incidence of psychotic disorders has either been stable or decreasing ...
"It is dire," Stanford Biodesign's Josh Makower said as he discussed how medtech reimbursement is “throttling” innovation.
News Medical on MSN
Novel RNA molecule may influence patient survival in certain blood cancers
In a recent study published in the Proceedings of the National Academy of Sciences (PNAS), researchers at the Texas A&M University Health Science Center (Texas A&M Health) identify a novel RNA ...
Explore the Sequoia Fund Q4 2025 update on Elevance Health's performance and market outlook. Read the full shareholder letter ...
After years of rapid digital adoption, health system CIOs are entering a more stable phase of technology strategy shaped by persistent margin pressure, workforce strain and growing expectations that ...
Medicare Advantage health plans are blasting a government proposal this week that would keep their reimbursement rates flat next year while making other payment changes. But some health policy ...
Kahimmune Therapeutics signs exclusive licensing agreement with Gustave Roussy and SATT Paris-Saclay
Newly created spin-off of Gustave Roussy and SATT Paris-Saclay specializing in immuno-oncology will exploit hidden genome, also known as dark genome or non-coding genomeIt intends to develop a first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results